Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 21, 2009 08:15 ET | Source: Icagen, Inc.

Icagen Announces Extension of Pfizer Collaboration

RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced a one year extension to a prior worldwide collaboration and licensing agreement with Pfizer...
September 01, 2009 08:00 ET | Source: Icagen, Inc.

Icagen Reports Top Line Results of Phase IIa Study of Senicapoc in Allergic Asthma

RESEARCH TRIANGLE PARK, N.C., Sept. 1, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today top line results of a randomized, double-blind, placebo-controlled, proof-of-mechanism Phase...
August 31, 2009 08:00 ET | Source: Icagen, Inc.

Icagen to Present At Upcoming Healthcare Conferences

RESEARCH TRIANGLE PARK, N.C., Aug. 31, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in two upcoming healthcare conferences as follows:...
August 04, 2009 08:00 ET | Source: Icagen, Inc.

Icagen Reports Second Quarter 2009 Financial Results

RESEARCH TRIANGLE PARK, N.C., Aug. 4, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the second quarter ended June 30, 2009....
August 03, 2009 06:30 ET | Source: Icagen, Inc.

Icagen Announces Lifting of Partial Clinical Hold of ICA-105665

RESEARCH TRIANGLE PARK, N.C., Aug. 3, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today that the FDA has lifted the partial clinical hold related to the development of ICA-105665, the...
July 23, 2009 08:00 ET | Source: Icagen, Inc.

Icagen to Report Second Quarter 2009 Results On August 4, 2009

RESEARCH TRIANGLE PARK, N.C., July 23, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release second quarter 2009 financial results on Tuesday, August 4, 2009 before the...
June 12, 2009 08:00 ET | Source: Icagen, Inc.

Icagen Completes Enrollment in Phase II Exercise Induced Asthma Trial

RESEARCH TRIANGLE PARK, N.C., June 12, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported the completion of enrollment in the Company's Phase II proof-of-concept study of senicapoc in...
June 04, 2009 16:36 ET | Source: Icagen, Inc.

Icagen Provides Strategic Update

RESEARCH TRIANGLE PARK, N.C., June 4, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that the Company has retained J.P. Morgan to provide advice and assistance on a range of...
May 05, 2009 08:00 ET | Source: Icagen, Inc.

Icagen Reports First Quarter 2009 Financial Results and Operational Highlights

RESEARCH TRIANGLE PARK, N.C., May 5, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the first quarter ended March 31, 2009. For...
April 24, 2009 08:00 ET | Source: Icagen, Inc.

Icagen to Report First Quarter 2009 Results On May 5, 2009

RESEARCH TRIANGLE PARK, N.C., April 24, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release first quarter 2009 financial results on Tuesday, May 5, 2009 before the...